AIDS TREATMENT NEWS Selected Index

Readers of AIDS TREATMENT NEWS often write to ask us if we
ever reported on a particular treatment or diagnosis. The first
75 issues of the newsletter are thoroughly indexed in our book,
AIDS TREATMENT NEWS, published by Celestial Arts, of Berkeley,
California. But no such index has been available for issues #76
through the present.

The following selective index is maintained and used in our
office to answer inquiries. It does not include every possible
reference from our back issues, only those which still seem
substantial or relevant. For information concerning topics not
addressed by AIDS TREATMENT NEWS, we recommend the following
other publications to our readers:

*AmFAR's AIDS/HIV Experimental Treatment Directory: 212/719-0033.

*Bulletin of Experimental Treatments for AIDS (BETA): 863-2437
in San Francisco, 800/327-9893 rest of U. S.

*Directory of Antiviral and Immunomodulatory Therapies for AIDS
(DAITA): 205/991-6920.

*PI Perspectives and Project Inform fact sheets: 558-9051 in San
Francisco, 800/334-7422 rest of California, 800/822-7422 rest of
U. S. ; 415/558-9051 from other countries.

*Treatment and Data Digest of ACT UP/New York: 155 E. 31st
Street, Suite #20-L, New York, NY 10016.

*Treatment Issues, published by Gay Men's Health Crisis:
212/337-1950.


Article Issue Numbers

ACT UP 82, 101, 103, 106, 108, 111, 112,117
acyclovir (Zovirax) 83, 94, 108, 115
aerosol pentamidine 88, 90, 114
AL 721 (egg lecithin/lipids) 42, 43, 44, 55
alpha interferon 75, 87, 101
amikacin 109
amphotericin 41, 58
Ampligen 34, 67
Antabuse (disulfiram) 29, 70
anemia 82
anti-idiotype antibody therapy 93, 110
Asacol 109
ascorbate 111
aspirin 109
AzdU (azidouridine, CS-87) 72
azithromycin 75, 79, 108, 109, 111, 113
AZT (zidovudine, Retrovir) 83, 86, 90, 95, 100, 107, 110,
113, 115
Bactrim (co-trimoxazole, TMP-SMX) 108, 114
benefits 74, 76, 105
BHT 10, 71
BI-RG-587 117
bleomycin 73
blue-green algae (sulfolipids) 87, 99
buyers' clubs 117
candidiasis (thrush) 37, 96
castanospermine 35
CDA (chlorodeoxyadenosine) 93, 110
CD4 (recombinant soluble) 62
chemotherapy 73, 75, 93, 110
children/infants 90, 114, 117
Chinese medicine 61, 68, 75, 93, 107
Chronic Fatigue Syndrome (CFIDS) 93
cimetidine (Tagamet) 80
clarithromycin 109, 113
clindamycin 79, 104, 108, 111
clofazimine (Lamprene) 79, 109
CMV 71, 76, 83, 89, 94, 96, 108, 110
coccidioidomycosis (valley fever) 41, 96
cofactors 83, 108
coenzyme Q (ubiquinone) 26
combination therapies 107, 115
community research 65, 66, 83, 85
compound Q (GLQ 223, trichosanthin) 82, 88, 99, 104
computerized information 83, 102, 114, 116
CPFs 108
cryptococcal meningitis 41, 58, 96, 99
cryptosporidiosis 49, 58, 75, 80, 95, 107, 111, 113
cytarabine (ARA-C) 79, 93
d4T 72
dapsone 79, 114
ddC 89, 103, 104, 112, 113, 115
ddI 83, 88, 99, 103, 110, 112
dementia 97, 101
dextran sulfate 50, 76, 89
dexamethasone (Decadron) 79, 88, 93
DHEA (EL 10) 48, 49, 84
diagnosis accuracy 100, 111
diclazuril (Clinicox) 80, 95, 107, 111
DNCB 14, 116
doctor/patient relations 100, 111
doxorubicin (Adriamycin) 73
doxycycline 95, 104, 108
D-penicillamine 35
DTC (Imuthiol) 29, 70, 114
eflornithine (DFMO) 94, 95
encephalitis 79, 97
epidemiology 97, 99
EPO (erythropoietin) 82
Epstein-Barr Virus (EBV) 93, 94
etoposide 73
Fansidar 42, 108, 114
FIAC 94
566C80 108, 109, 114
FLT (fluorodeoxythymidine) 72
fluconazole (Diflucan) 41, 58, 80, 96, 103
Foscarnet 71, 83, 94, 108, 110
funding/lobbying 97, 99, 111
fusidic acid (Fusidin) 42, 79
gamma interferon 108
ganciclovir (DHPG, Cytovene) 71, 89, 94, 96, 108
gentamicin 109
germanium 90
glycyrrhizin 17, 103, 115
GM-CSF 87, 93, 94, 105, 108, 110
health care politics 99, 102, 103, 111, 112
hemophilia 89, 102, 103
heparin 100
herpes/shingles 80, 83, 94, 100, 115
histoplasmosis 41, 96
HOE/BAY 964 59
HPMPC 76, 96
Humatin (paromomycin) 107, 111
hybridons (anti-sense) 58
hydrogen peroxide 49
hypericin 80, 86, 88, 91, 96
hyperimmune milk (colostrum) 49, 95, 107
hyperthermia 104
ibuprofen (Advil) 109
immigration 89, 98, 114
Imuthiol (DTC) 29, 70, 114
indomethacin 109
infection prevention 79, 90
insurance 74, 76
interferons 75, 87, 101, 114
Iscador (mistletoe compound) 92
isoprinosine 106
ITP 48
itraconazole (Sporanox) 80, 96
Kaposi's sarcoma (KS) 73, 75, 87, 99, 100
Kemron 97, 101, 114
laser treatments 75, 96
lentinan 19, 73
leucovorin 49, 52, 79
liposomes 109
L671,329 114
lymphoma 93, 110
MAI/MAC 79, 109, 113
mebeciclol 95
Megace (megestrol acetate) 76, 77
MEK 99
melanins 107
mitoxantrone 93
mycoplasma 95, 108
NAC 88, 92, 93
naltrexone 16, 52
neopterin 86, 100
neutropenia 94, 100
neuropsychiatric effects 97, 101
nonsteroidal anti-inflammatory drugs 109
nutrition 73
ozone 80
parallel track 82, 84, 85, 104
paromomycin (Humatin) 107, 111
passive immunotherapy 67, 92
patient/doctor relations 100, 111
PCR 62
pediatric AIDS 90, 117
people of color 86, 99
Peptide T 84
Persantine (dipyridamole) 79
pharmacies 64, 86
physician interviews 47, 54, 56, 62, 100, 106
PML 79, 88, 100, 115
Pneumocystis pneumonia (PCP) 58, 83, 90, 106, 114, 115
polio vaccine 45
pregnancy 90
primaquine 113
prisoners 106
prophylaxis/prevention 79, 94, 100, 106, 108, 114
propolis 37
Prosorba column 75
PWA coalitions 117
pyrimethamine (Daraprim) 79, 104, 108, 114
radiation therapy 73, 93, 110
research priorities & policy 60, 62, 67, 77, 78, 81, 85,
104, 105, 110, 112, 116
R-HEV test 85
rifabutin (Ansamycin) 53, 79, 109
rifampin 79, 102
roxithromycin 75, 81, 95
Salk vaccine (HIV) 98
scabies 98
SCH 39304 99
Septra (co-trimoxazole, TMP-SMX) 79, 108, 114
shiitake 19
somatostatin (Sandostatin) 58, 95
spiramycin 49, 79, 95, 107
steroids 114, 115
sulfadiazine 79, 93, 104, 108
sulfolipids (blue-green algae) 87, 99
sunlight 58
Tagamet (cimetidine) 80
thrush (candidiasis) 37, 96
TIBO derivatives 97
TI-23 108
TLC G-65 109
toltrazuril (Baycox) 111
toxoplasmosis 79, 104, 108, 109, 113
transfer factor 47
treatment access 83, 84, 85, 115, 116
treatment strategy 83, 100, 111
trifluridine (Viroptic) 115
trimethoprim/sulfamethoxazole 79, 108, 114
trimetrexate/leucovorin 49, 52, 108
tuberculosis 106
tumor necrosis factor 87, 88
valley fever (coccidioidomycosis) 41, 96
vidarabine (Vira-A) 79, 94
vinblastine, vincristine 73
vitamin C 111
wasting syndrome 76, 77, 88
women 65, 90, 111, 112, 115



Statement of Purpose

AIDS TREATMENT NEWS reports on experimental and
complementary treatments, especially those available now. It
collects information from medical journals, and from interviews
with scientists, physicians, and other health practitioners, and
persons with AIDS or HIV.

Long-term survivors have usually tried many different
treatments, and found combinations which work for them. AIDS
TREATMENT NEWS does not recommend particular therapies, but seeks
to increase the options available.

We also examine the ethical and public-policy issues around
AIDS treatment research and treatment access.